NATR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Natures Sunshine Products Inc · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 20.15 USD
-1.2% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 47.3% of its 52-week range. The latest completed week returned -1.2%, after a -6.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. Options positioning is bullish with 48/100 conviction, while the latest news-sentiment score is 53/100. Near-term considerations: volume confirmation is below normal.

Setup score 29 out of 100
Latest Close 20.15 USD 31 Jul 2026
1W Return -1.2% latest completed week
4W Return -6.1% short-term follow-through
12W Return -16.8% quarterly tape
Trend Breadth 75.0% 39 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.60% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.2% Latest completed week; four-week move -6.1%. Indicator stack 41/23 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.60% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 48/100 conviction; expected move 7.7%. News sentiment 53/100 35 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -14.6% below the Trend Line and sits at 47.3% of its 52-week range. The latest completed week returned -1.2%, after a -6.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1112-week average 0.48

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -6.1% over four weeks, -16.8% over 12 weeks, and 27.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.2%
4W-6.1%
12W-16.8%
26W-20.1%
52W27.5%
Active trend streak0 weeks
Active weeks in one year39
Trend breadth75.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.37Latest activity-pressure read.
Pressure change-25.9%Four-week change in activity pressure.
Leadership-12.92Latest relative-leadership reading.
RS change-29.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength97/100Blend of value, momentum, and quality. Underlying universe rank 4; rank 1 is best.
Value88/100Relative valuation strength. Underlying universe rank 13; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth69/100Revenue and earnings growth. Underlying universe rank 32; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework84/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.0x
Price divided by trailing earnings.
Price / sales
0.7x
Market value relative to trailing revenue.
EV / EBITDA
6.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
72.7%
Gross profit retained from each unit of revenue.
Operating margin
6.3%
Operating profit retained from revenue.
Free-cash-flow margin
7.9%
Free cash flow generated from revenue.
Return on invested capital
20.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
7.3%
Latest one-year revenue growth.
EPS growth
96.5%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
13.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
4.6%
Net share repurchases relative to market value.
Shareholder yield
4.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

NATR shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 7.7%, and Sharemaestro trend signal inactive.

Conviction48/100
Expected move7.7%
Put/call volume0.00
Pressure100
Speculation1
Volatility53
Trend agreement0
Open options detail
Insider activity14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment53/100

Weighted news tone is neutral across 35 relevant articles.

9 positive · 24 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move7.7%Nearest-chain priced movement where available.
52-week drawdown-28.4%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+11.1%Week of 10 Apr.
Worst week-9.5%Week of 6 Mar.
Latest week-1.2%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains7
Flat weeks0
Modest losses12
Sharp losses4
Recent vol4.1%13-week weekly-return volatility.
Base vol6.7%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew6.0% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape30/100

Trend, activity pressure, participation, and risk combine to a 30/100 tape read.

 Indicator analysis12/100

Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 43.60%

Next-week expectancy is negative with a 43.60% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors88/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 13; Small Cap Core rank 21 SVQF84/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 115.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

NATR shows bullish options pressure with a 48/100 conviction score, put-call volume ratio of 0.00, expected move of 7.7%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 7.7% Sentiment53/100

Weighted news tone is neutral across 35 relevant articles.

Nature's Sunshine Products Inc (NATR) Risk Assessment: Volatility, Financial Risk & Investment Risk Insiders14 / 6

14 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.15 USD-1.2%23.59 USD17.46 USD-1.37-12.92515.3KOff
24 Jul 202620.40 USD-0.1%23.62 USD17.42 USD-1.21-11.32518.0KOff
17 Jul 202620.43 USD-3.9%23.66 USD17.38 USD-1.06-12.42412.7KOff
10 Jul 202621.27 USD-0.9%23.72 USD17.33 USD-1.01-12.47404.0KOff
3 Jul 202621.47 USD2.1%23.77 USD17.28 USD-1.09-9.99660.8KOff
26 Jun 202621.02 USD4.5%23.78 USD17.23 USD-1.20-11.02763.2KOff
19 Jun 202620.12 USD-1.9%23.77 USD17.18 USD-1.35-18.51608.5KOff
12 Jun 202620.51 USD3.6%23.80 USD17.14 USD-1.31-14.75583.2KOff
5 Jun 202619.79 USD-7.0%23.83 USD17.09 USD-1.26-15.80928.9KOff
29 May 202621.28 USD-2.6%23.76 USD17.04 USD-1.23-13.50583.5KOff
22 May 202621.85 USD-1.7%23.50 USD16.98 USD-1.01-8.67674.1KOff
15 May 202622.22 USD-8.3%23.24 USD16.91 USD-0.79-5.87589.6KOn
8 May 202624.23 USD-9.1%22.98 USD16.84 USD-0.542.47446.6KOn
1 May 202626.66 USD-2.5%22.66 USD16.75 USD-0.3019.34303.1KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.